| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 27 |
| 1 | RIBOCICLIB | 17 |
| 2 | FLUOROURACIL | 16 |
| 3 | FLUOROURACIL CREAM, 0.5% | 16 |
| 4 | PEMBROLIZUMAB | 16 |
| 5 | FULVESTRANT | 15 |
| 6 | PACLITAXEL | 15 |
| 7 | CYCLOPHOSPHAMIDE | 14 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROQUINONE | 2 | 0.0034 |
| 1 | IBRITUMOMAB TIUXETAN | 5 | 0.0033 |
| 2 | TALIMOGENE LAHERPAREPVEC | 5 | 0.0031 |
| 3 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 4 | NIROGACESTAT | 1 | 0.0011 |
| 5 | ACETAZOLAMIDE SODIUM | 6 | 0.0010 |
| 6 | IXABEPILONE | 1 | 0.0010 |
| 7 | ETHIODIZED OIL | 1 | 0.0008 |
| 8 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 9 | METHYLENE BLUE | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |
| 1 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 2 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 3 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 4 | Estrogen Receptor Antagonist [EPC] | 17 | 0.0004 |
| 5 | Carbonic Anhydrase Inhibitor [EPC] | 6 | 0.0003 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 27 | 0.0003 |
| 7 | Cannabinoid [EPC] | 2 | 0.0002 |
| 8 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |